Camrelizumab plus gemcitabine and oxaliplatin (GEMOX) in patients with advanced biliary tract cancer: a single-arm, open-label, phase II trial
==============================================================================================================================================

* Xiaofeng Chen
* Xiaofeng Wu
* Hao Wu
* Yanhong Gu
* Yang Shao
* Qianwen Shao
* Feipeng Zhu
* Xiao Li
* Xiaofeng Qian
* Jun Hu
* Fengjiao Zhao
* Weidong Mao
* Jing Sun
* Jian Wang
* Gaohua Han
* Changxian Li
* Yongxiang Xia
* Poshita Kumari Seesaha
* Dongqin Zhu
* Huajun Li
* Junling Zhang
* Guoqiang Wang
* Xuehao Wang
* Xiangcheng Li
* Yongqian Shu